NECTRANT Trademark

Trademark Overview


On Tuesday, May 14, 2019, a trademark application was filed for NECTRANT with the United States Patent and Trademark Office. The USPTO has given the NECTRANT trademark a serial number of 79261549. The federal status of this trademark filing is REGISTERED as of Tuesday, January 28, 2020. This trademark is owned by Glaxo Group Limited. The NECTRANT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

General Information


Serial Number79261549
Word MarkNECTRANT
Filing DateTuesday, May 14, 2019
Status700 - REGISTERED
Status DateTuesday, January 28, 2020
Registration Number5969890
Registration DateTuesday, January 28, 2020
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 12, 2019

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, June 28, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type11 - Company
AddressGB

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type11 - Company
AddressGB

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type11 - Company
AddressGB

Trademark Events


Event DateEvent Description
Thursday, June 27, 2019SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, June 28, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sunday, July 7, 2019NON-FINAL ACTION WRITTEN
Saturday, July 27, 2019REFUSAL PROCESSED BY MPU
Saturday, July 27, 2019NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, August 16, 2019REFUSAL PROCESSED BY IB
Tuesday, July 2, 2019APPLICATION FILING RECEIPT MAILED
Thursday, July 4, 2019ASSIGNED TO EXAMINER
Monday, July 8, 2019NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, September 30, 2019ASSIGNED TO LIE
Monday, September 23, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, October 4, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, October 4, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, October 4, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 23, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, October 23, 2019NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, October 23, 2019NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Saturday, November 9, 2019NOTIFICATION PROCESSED BY IB
Tuesday, November 12, 2019PUBLISHED FOR OPPOSITION
Tuesday, November 12, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 28, 2020REGISTERED-PRINCIPAL REGISTER
Friday, May 8, 2020FINAL DISPOSITION PROCESSED
Friday, May 8, 2020FINAL DISPOSITION NOTICE SENT TO IB
Friday, May 29, 2020FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, May 30, 2025NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, January 28, 2025COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Tuesday, April 28, 2020FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Friday, August 11, 2023CHANGE OF NAME/ADDRESS REC'D FROM IB